Hematologic malignancies-sixth European congress. 26-28 February 2010, Cannes, France .
The sixth European Congress on Hematologic Malignancies--From Clinical Science to Clinical Practice, held in Cannes, France, included topics covering new therapeutic developments for different lymphoma entities, and provided a comprehensive overview on the latest advances in understanding of the biology of different lymphoma subtypes. This conference report highlights selected presentations on treatment options for multiple myeloma and chronic lymphocytic, follicular and mantle cell lymphomas, as well as B-cell non-Hodgkin's lymphoma, T-cell peripheral lymphoma and Hodgkin's lymphoma.
Buske
Christian
C
Institut für Experimentelle Tumorforschung des CCC Ulm, Universitätsklinikum Ulm und Klinik für Innere Medizin III, Albert-Einstein-Allee 11, 89081 Ulm, Germany. christian.buske@uni-ulm.de
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents